Sang Mok Lee, President, Chief Executive Officer and Director
Dr. Lee has been the President and CEO of the Target since its inception in 2005. Dr. Lee holds a PhD in microbiology from Busan National University in Korea and is currently an adjunct professor in microbiology at Chungnam National University. Dr. Lee is a committee member for the hi-tech medical complex city in Daejoen, Korea and a committee member of KOFST (the Korean Federation of Science and Technology Societies).
Konstantin Lichtenwald – Chief Financial Officer and Director
Mr. Lichtenwald has over ten years of finance and accounting experience, including corporate compliance, accounting and financial management and IPO, RTO services. Mr. Lichtenwald offers extensive knowledge and know-how for companies in two key financial jurisdictions, North America and German speaking parts of Europe. His accounting, financial skills offer a multi-faceted hands on approach to strategic management and problem solving.
Mr. Lichtenwald specializes in providing corporate finance, valuation, taxation, financial reporting, consulting and other accounting services to both small businesses as well as public commodity resource companies. Mr. Lichtenwald also assists in many aspects of clients’ administration, financing and other activities. Mr. Lichtenwald also worked at Ernst & Young GmbH, Germany, in the assurance department. Mr. Lichtenwald earned his bachelor of business administration degree from Pforzheim University, Germany, and holds the professional designation of Chartered Professional Accountant (CPA, CGA) and Chartered Certified Accountant (ACCA), where he is a member of Chartered Professional Accountants of B.C. and Canada as well as a member of the Association of Chartered Certified Accountants of United Kingdom. Mr. Lichtenwald has had extensive experience as a controller and CFO of numerous publicly traded and private corporations in several industries.
Marco Nonni – Director
Mr. Nonni graduated from Santa Clara University with a Bachelor of Science Degree in 1989 and has over 16 years of experience with Biotech and top ten Pharmaceuticals companies in business development activities in the life science industry. He will be focusing on building key partnership for the advancement of the company.
Throughout his career, he has have provided leadership and management within Clinical Development for medical and scientific support to products within assigned therapy areas such as Oncology, Cardiovascular, Metabolic, and Rare Genetic Disorders. In addition, he has also supported the development and execution of medical and clinical strategies for assigned products. Mr. Nonni has overseen Clinical and Regulatory cycle and data generation, including medical monitoring, from Phase I-IV clinical research programs ensuring that requirements (from regulatory authorities, stakeholders, and quality standards) were met.
Sang Goo (Collin) Kim – Director
Mr. Kim holds a bachelor degree of business administration from Korea University, Seoul, Korea. Mr. Kim came to Vancouver, Canada in 2006 after working for Hanwha Corp., one of Korean business conglomerates for 16 years, where he was dedicated to International trading business for various industrial products. He has been working as a Vice President for Columbia Capital since 2008 and a director of ArcPacific Resources Corp., a public Canadian junior exploration company, since 2015. He is actively working on several projects and business opportunities with Canadian firms and major Korean state-owned firms to utilize his vast knowledge and work experience.